EMEA-000997-PIP01-10-M02

Key facts

Invented name
Uptravi
Active substance
Selexipag
Therapeutic area
Other
Decision number
P/0123/2019
PIP number
EMEA-000997-PIP01-10-M02
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of pulmonary arterial hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Janssen Cilag International NV

Switzerland
clinical-trials-disclosure@its4nj.com
Tel. +41 6165656456

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating